Company Registration No. 08260301 (England and Wales)
Irislab Limited
Unaudited accounts
for the year ended 31 October 2025
Irislab Limited
Unaudited accounts
Contents
Irislab Limited
Company Information
for the year ended 31 October 2025
Director
Mr Matthew D'haemer
Company Number
08260301 (England and Wales)
Registered Office
Cca, Sussex Innovation Centre
Science Park Square
Brighton
BN1 9SB
England
Accountants
Collective Concepts Accounting Ltd
Irislab Limited
Statement of financial position
as at 31 October 2025
Tangible assets
8,817
6,577
Cash at bank and in hand
1,186
1,944
Creditors: amounts falling due within one year
(116,344)
(76,832)
Net current liabilities
(104,735)
(61,877)
Total assets less current liabilities
(95,918)
(55,300)
Creditors: amounts falling due after more than one year
(500)
(3,500)
Net liabilities
(96,418)
(58,800)
Called up share capital
100
100
Profit and loss account
(96,518)
(58,900)
Shareholders' funds
(96,418)
(58,800)
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 16 July 2026 and were signed on its behalf by
Mr Matthew D'haemer
Director
Company Registration No. 08260301
Irislab Limited
Notes to the Accounts
for the year ended 31 October 2025
Irislab Limited is a private company, limited by shares, registered in England and Wales, registration number 08260301. The registered office is Cca, Sussex Innovation Centre, Science Park Square, Brighton, BN1 9SB, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% Reducing Balance
Computer equipment
25% Reducing Balance
The directors have prepared the financial statements on a going concern basis. The company continues to be supported by its director, who has provided funding through a director's loan account and has confirmed that financial support will continue.
The directors have reviewed cash flow forecasts and, based on the continued support of the director, consider that the company will be able to meet its liabilities as they fall due.
Accordingly, the financial statements have been prepared on the going concern basis.
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Irislab Limited
Notes to the Accounts
for the year ended 31 October 2025
4
Tangible fixed assets
Plant & machinery
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 November 2024
10,753
8,189
18,942
At 31 October 2025
11,253
12,858
24,111
At 1 November 2024
7,072
5,293
12,365
Charge for the year
1,045
1,884
2,929
At 31 October 2025
8,117
7,177
15,294
At 31 October 2025
3,136
5,681
8,817
At 31 October 2024
3,681
2,896
6,577
Amounts falling due within one year
Amounts due from group undertakings etc.
-
8,761
Accrued income and prepayments
5,944
-
6
Creditors: amounts falling due within one year
2025
2024
Bank loans and overdrafts
3,000
3,025
Loans from directors
113,344
73,719
7
Creditors: amounts falling due after more than one year
2025
2024
8
Transactions with related parties
At the year end, an amount of £10,657 (2024: £8,761) was due from Healthdatalab Ltd, an entity under common control.
The outstanding balance has been written off following the dissolution of Healthdatalab Ltd on 6 January 2026.
9
Average number of employees
During the year the average number of employees was 2 (2024: 2).